NIH-funded research R15 grant

Understanding how bacteria defend against viruses using the BREX system

Official title: Characterization of the Bacterial BREX Phage Restriction System

Funded at Seattle University · NIH-10291285 · Data updated 2026-11-12

This study is looking at how certain bacteria defend themselves against viruses, focusing on a special system they use to tell their own DNA apart from that of the viruses, which could help us find new ways to use this knowledge in science and technology.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionSeattle University
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 15, 2021
Project endAugust 31, 2025
Funding year2021
Award (this year)$284,000
NIH project number1R15GM140375-01A1
Project IDNIH-10291285 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to bacterial infections or those interested in the mechanisms of microbial resistance.

Less likely to help

Patients with viral infections that do not involve bacterial co-infections may not benefit from this research.

What this research studies

This research investigates a bacterial defense mechanism known as the BREX system, which helps bacteria protect themselves from viral infections. By examining the genes and proteins involved in this system, researchers aim to uncover how bacteria can distinguish between their own DNA and that of invading viruses. The study employs advanced techniques, including cryo-electron microscopy, to visualize the components of the BREX system and understand their functions. This knowledge could lead to new insights into bacterial resistance and potential applications in biotechnology.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of bacterial defenses, potentially leading to novel strategies for preventing bacterial infections.

How similar studies have gone: While the BREX system is relatively uncharacterized, similar bacterial defense mechanisms have shown promise in previous studies, indicating potential for success in this area.

Where this research is happening

  • Seattle University
    Seattle, United States
    Active

Researchers

  • Principal investigator: Kaiser, Brett Kian — Seattle University
  • Study coordinator: Kaiser, Brett Kian

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.